Organigram Global Inc. Common Shares (OGI)
OGI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 40-F (ifrs-full:Revenue), period ending 2024-09-30, https://www.sec.gov/Archives/edgar/data/1620737/000162828024051826/0001628280-24-051826-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLoss), period ending 2024-09-30. Converted from CAD at 1.4219 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | OGI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001620737 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | Z4 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $112.4M |
| Net income | -$32.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | -28.4% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Reported in CAD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2025-12-16 |
| Latest quarterly / interim | 6-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 319 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KRRO | Korro Bio Inc. | $8.81 | -5.98% | $129.7M |
| RNA | Atrium Therapeutics Inc. | $7.75 | -5.60% | $132.6M |
| KZIA | Kazia Therapeutics Limited | $8.04 | -8.74% | $125.0M |
| ALXO | ALX Oncology Holdings Inc. | $0.9796 | -22.25% | $135.5M |
| ANTX | AN2 Therapeutics Inc. | $3.60 | -16.28% | $135.9M |
| TLSA | Tiziana Life Sciences Ltd. Common Shares | $1.09 | 0.00% | $138.7M |
| NERV | Minerva Neurosciences Inc | $2.52 | -12.98% | $120.1M |
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier